Volume 65, Issue 2, Pages (February 2004)

Slides:

Advertisements

Similar presentations

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Advertisements

Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery Wolfgang C. Winkelmayer, Robert J. Glynn,

Confounding: What it is and how to deal with it

Blaithin A. McMahon, Patrick Thomas Murray Kidney International

Volume 85, Issue 2, Pages (January 2014)

Volume 81, Issue 4, Pages (February 2012)

Prehypertension and chronic kidney disease: the ox or the plow?

Continuous renal replacement therapy in the critically ill patient

John P. Middleton, Patrick H. Pun Kidney International

Volume 56, Issue 2, Pages (August 1999)

Volume 78, Issue 8, Pages (October 2010)

Yasuhiro Hamada, Masafumi Fukagawa Kidney International

Volume 58, Issue 1, Pages (July 2000)

Volume 77, Issue 8, Pages (April 2010)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Peripheral microvascular parameters in the nephrotic syndrome

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 77, Issue 1, Pages 5-6 (January 2010)

Volume 66, Issue 3, Pages (September 2004)

Volume 68, Issue 5, Pages (November 2005)

Targets to retard the progression of diabetic nephropathy

Volume 79, Issue 8, Pages (April 2011)

Predicting an allograft's fate

Volume 87, Issue 2, Pages (February 2015)

Volume 77, Pages S8-S11 (March 2010)

Volume 75, Issue 1, Pages (January 2009)

Timothy A. Sutton, Pierre C. Dagher Kidney International

U-shaped effect of eGFR and mortality

Volume 75, Issue 11, Pages (June 2009)

Volume 70, Issue 1, Pages (July 2006)

Should kidney donors be genotyped for APOL1 risk alleles?

Immunosuppression in liver transplant recipients with renal impairment

The third World Kidney Day: Looking back and thinking forward

Volume 56, Issue 2, Pages (August 1999)

Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation? Lionel Rostaing, Nassim Kamar Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Methods for guideline development

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 85, Issue 1, Pages 3-4 (January 2014)

Simvastatin in nephrotic syndrome

Volume 66, Issue 3, Pages (September 2004)

Nephrology Crossword: Glomerulonephritis

Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen

Volume 71, Issue 4, Pages (February 2007)

Volume 85, Issue 5, Pages (May 2014)

Volume 80, Issue 3, Pages (August 2011)

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Douglas G Matsell, Colin T White Kidney International

Volume 82, Issue 3, Pages (August 2012)

Volume 79, Issue 4, Pages (February 2011)

Current status of maintenance hemodialysis in Beijing, China

Organ transplantation goes to the movies

Volume 60, Issue 1, Pages (July 2001)

Blood lead and chronic kidney disease in the general United States population: Results from NHANES III Paul Muntner, Jiang He, Suma Vupputuri, Josef.

Volume 80, Issue 10, Pages (November 2011)

Cellular contributions to glomerular size-selectivity

Volume 74, Issue 3, Pages (August 2008)

The hypothesis that abnormal BH4 metabolism impairs kidney function

ANCA comes of age—but with caveats

Volume 70, Issue 5, Pages (September 2006)

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Arya M. Sharma, Joachim Beige, Armin Distler Kidney International

Adiponectin: good, bad, or just plain ugly?

Volume 55, Issue 3, Pages (March 1999)

The international realities of live donor kidney transplantation

The International Pediatric Peritonitis Registry: Starting to walk

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

Volume 72, Issue 12, (December 2007)

Presentation transcript:

Volume 65, Issue 2, Pages 692-699 (February 2004) The effect of maintenance immunosuppression medication on the change in kidney allograft function John S. Gill, Marcello Tonelli, Christian H. Mix, Nathan Johnson, Brian J.G. Pereira Kidney International Volume 65, Issue 2, Pages 692-699 (February 2004) DOI: 10.1111/j.1523-1755.2004.00431.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Patient disposition according to maintenance calcineurin and purine metabolism inhibitor use. Kidney International 2004 65, 692-699DOI: (10.1111/j.1523-1755.2004.00431.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 The annualized change in glomerular filtration rate (GFR) and 95% CI for patients who received different maintenance calcineurin and purine metabolism inhibitors. The medication effects were calculated from a multiple linear regression analysis that included donor, recipient, and immunologic factors. Neoral (A) and azathioprine (B) are the reference calcineurin and purine metabolism inhibitors. Kidney International 2004 65, 692-699DOI: (10.1111/j.1523-1755.2004.00431.x) Copyright © 2004 International Society of Nephrology Terms and Conditions